Medtech Acquisition Stock Current Valuation
| MTACWDelisted Stock | USD 0.10 0.00 0.00% |
Valuation analysis of MedTech Acquisition helps investors to measure MedTech Acquisition's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that MedTech Acquisition's price fluctuation is very steady at this time. Calculation of the real value of MedTech Acquisition is based on 3 months time horizon. Increasing MedTech Acquisition's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MedTech stock is determined by what a typical buyer is willing to pay for full or partial control of MedTech Acquisition. Since MedTech Acquisition is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MedTech Stock. However, MedTech Acquisition's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.0809 | Hype 0.1 |
The intrinsic value of MedTech Acquisition's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MedTech Acquisition's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MedTech Acquisition helps investors to forecast how MedTech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MedTech Acquisition more accurately as focusing exclusively on MedTech Acquisition's fundamentals will not take into account other important factors: MedTech Acquisition Company Current Valuation Analysis
MedTech Acquisition's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, MedTech Acquisition has a Current Valuation of 0.0. This indicator is about the same for the Metals & Mining average (which is currently at 0.0) sector and about the same as Materials (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
MedTech Acquisition is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Materials industry is now estimated at about 159.67 Million. MedTech Acquisition adds roughly 0.0 in current valuation claiming only tiny portion of all equities under Materials industry.MedTech Fundamentals
| Number Of Shares Shorted | 7.89 K | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 25 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Cash Flow From Operations | (2.74 M) | |||
| Market Capitalization | 306.25 M | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
| Working Capital | (2.14 M) | |||
| Z Score | 75.01 | |||
| Net Asset | 20.19 M |
About MedTech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedTech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedTech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedTech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |